StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Seres Therapeutics (MCRB) PT Lowered to $18 at Oppenheimer
March 9, 2018 2:12 AM
Oppenheimer lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Seres Therapeutics (MCRB) PT Lowered to $13 at Leerink Partners
March 9, 2018 1:43 AM